Convalescent hyperimmune plasma in patients with hematologic malignancies and severe COVID-19 infections

Alain Mina^{1

2}, Sara Small^{1

2}, Leonidas C Platanias^{1

2

3}

Affiliations

¹ Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
² Division of Hematology-Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
³ Department of Medicine, Jesse Brown Veterans Affairs Medical Center, Chicago, IL, USA.

Comment

Alain Mina et al. Leuk Lymphoma. 2021 Jun.

. 2021 Jun;62(6):1284-1286.

doi: 10.1080/10428194.2021.1897808. Epub 2021 Mar 17.

Alain Mina^{1

2}, Sara Small^{1

2}, Leonidas C Platanias^{1

2

3}

¹ Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
² Division of Hematology-Oncology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
³ Department of Medicine, Jesse Brown Veterans Affairs Medical Center, Chicago, IL, USA.

No abstract available

Comment on

Convalescent hyperimmune plasma for chemo-immunotherapy induced immunodeficiency in COVID-19 patients with hematological malignancies.
Ferrari S, Caprioli C, Weber A, Rambaldi A, Lussana F. Ferrari S, et al. Leuk Lymphoma. 2021 Jun;62(6):1490-1496. doi: 10.1080/10428194.2021.1872070. Epub 2021 Jan 18. Leuk Lymphoma. 2021. PMID: 33461387 Free PMC article.